Murashko allowed the use of new therapeutic vaccines to begin in 2025

Russian scientists are conducting clinical and preclinical studies of new therapeutic vaccines that can be used before the end of 2025. This was announced on May 21 by Russian Minister of Health Mikhail Murashko during an expanded meeting with the heads of diplomatic missions of Latin American and Caribbean countries.

"Clinical studies and preclinical studies of several platforms are currently underway, which I hope will be actively used in clinical applications by the end of this year," he said.

The Minister stressed that the new vaccines will be used in the treatment of diseases. Murashko added that Russia is developing the production of personalized medical products in the field of orthopedics and neurosurgery.

Protective discovery: Russian Federation creates universal oncovaccine and breast cancer map

What opportunities for fighting the disease are demonstrated by domestic science

On April 10, the Federal Medical and Biological Agency (FMBA) announced that a domestic vaccine against allergy to birch pollen and a number of other sources is planned to be registered in late 2025–early 2026. During the tests, the drug has demonstrated its safety and specific activity. The production regulations for its release have also been developed.